Bring out your dead: A review of the cost minimization approach in health technology assessment submissions to the Australian Pharmaceutical Benefits Advisory Committee

Social Sciences

• technology assessment 93%
• pharmaceutical 72%
• costs 44%
• medicine 40%
• health 35%
• subsidy 33%
• methodology 28%
• linear model 12%
• evaluation 10%
• economics 9%
• literature 9%
• criticism 8%
• Healthcare 8%
• uncertainty 8%
• death 8%
• stakeholder 7%
• evidence 4%

Medicine & Life Sciences

• Biomedical Technology Assessment 100%
• Advisory Committees 83%
• Guidelines 50%
• Costs and Cost Analysis 48%
• Pharmaceutical Preparations 32%
• Cost-Benefit Analysis 19%
• Patient Compliance 10%
• Uncertainty 10%
• Health Care Costs 10%
• Linear Models 8%
• Health 5%